HyClone Laboratories Awards Design-Build Contract for $12 Million Expansion of Biotechnology Center

---

Researched by Industrialinfo.com (Industrial Information Resources, Inc.; Houston, Texas) Construction began in June 2001 for HyClone Laboratories Incorporated (Logan, Ut) $12 million biotechnology plant in Logan, Utah. Darrell Anderson Construction Company (Logan, Ut) was awarded the design-build contract for four new buildings. The new buildings will include an administration building, a warehouse and distribution building with cold and frozen storage, plus two manufacturing and production buildings that will house research and development, product development and Class 10,000 clean rooms. This expansion is expected to almost double employment on-site from 296 to 575 people and introduce new biotechnology products in response to growth in the biotechnology industry.

HyClone Laboratories, an international manufacturer and distributor of products for bio-pharmaceutical process applications and cell culture research and development, built their only U.S. manufacturing facility at the Logan site in 1981. HyClone was founded by Dr. Rex Spendlove to develop fetal bovine serum (FBS) and emerged as an international manufacturer and distributor of sera, serum alternatives, sterile liquids, bioprocess container systems used in cell culture research and bio-pharmaceutical process applications. HyClone has manufacturing and distribution offices in North America, South America, Africa, Europe, Asia and Australia. HyClone is an ISO 9001/ANSI/ASQC Q9001 certified company.